{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:23:53Z","timestamp":1758824633435,"version":"3.44.0"},"reference-count":26,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p>Drug-induced agranulocytosis is a rare, potentially fatal idiosyncratic reaction that can occur unpredictably with a wide variety of drugs when taken in a conventional dose. In this article, we discuss its diagnosis and management and we consider the drugs most commonly involved and ways of minimising risk. We do not consider the dose-related granulocytopenia that commonly complicates treatment with cytotoxic and other myelosuppressant drugs, nor the rarer reaction, aplastic anaemia.<\/jats:p>","DOI":"10.1136\/dtb.1997.35749","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"49-52","source":"Crossref","is-referenced-by-count":9,"title":["Drug-induced agranulocytosis"],"prefix":"10.1136","volume":"35","member":"239","published-online":{"date-parts":[[1997,7,1]]},"reference":[{"key":"2025082800042276000_35.7.49.1","unstructured":"Kaufman DW Kelly JP Levy M Shapiro S . The drug etiology of agranulocytosis and aplastic anemia Oxford: Oxford University Press 1991 148\u201358."},{"key":"2025082800042276000_35.7.49.2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes","volume":"79","author":"Julia","year":"1991","journal-title":"Br J Haematol"},{"key":"2025082800042276000_35.7.49.3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003495-198631010-00004","article-title":"Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms","volume":"31","author":"Vincent","year":"1986","journal-title":"Drugs"},{"key":"2025082800042276000_35.7.49.4","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198631010-00004"},{"key":"2025082800042276000_35.7.49.5","first-page":"279","article-title":"Immune and toxic mechanisms in drug-induced agranulocytosis","volume":"10","author":"Pisciotta","year":"1973","journal-title":"Semin Hematol"},{"key":"2025082800042276000_35.7.49.6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.297.6643.262","article-title":"International Agranulocytosis and Aplastic Anaemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs","volume":"297","year":"1988","journal-title":"BMJ"},{"key":"2025082800042276000_35.7.49.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6643.262"},{"key":"2025082800042276000_35.7.49.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411223112106"},{"key":"2025082800042276000_35.7.49.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390150107020"},{"key":"2025082800042276000_35.7.49.10","first-page":"2031","article-title":"The application of haematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases","volume":"8","author":"Sprikkelman","year":"1994","journal-title":"Leukemia"},{"key":"2025082800042276000_35.7.49.11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/dtb.1995.331292","article-title":"Co-trimoxazole use restricted","volume":"33","year":"1995","journal-title":"DTB"},{"key":"2025082800042276000_35.7.49.12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bjo.80.2.182","article-title":"Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?","volume":"80","author":"McGhee","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"2025082800042276000_35.7.49.13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.2.182"},{"key":"2025082800042276000_35.7.49.14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.483"},{"key":"2025082800042276000_35.7.49.15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/dtb.31.5.17","article-title":"Slow-acting antirheumatic drugs","volume":"31","year":"1993","journal-title":"DTB"},{"key":"2025082800042276000_35.7.49.16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.1983.00350040049004","article-title":"Captopril-associated neutropenia. Who is at risk?","volume":"143","author":"Cooper","year":"1983","journal-title":"Arch Intern Med"},{"key":"2025082800042276000_35.7.49.17","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1983.00350040049004"},{"key":"2025082800042276000_35.7.49.18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.3.381"},{"key":"2025082800042276000_35.7.49.19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/00003495-199753050-00005","article-title":"Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations","volume":"53","author":"de Lalla","year":"1997","journal-title":"Drugs"},{"key":"2025082800042276000_35.7.49.20","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199753050-00005"},{"key":"2025082800042276000_35.7.49.21","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90441-5"},{"key":"2025082800042276000_35.7.49.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/32.1.5"},{"key":"2025082800042276000_35.7.49.23","first-page":"1356","article-title":"Treatment of methimazole induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF)","volume":"77","author":"Tamai","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082800042276000_35.7.49.24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.5.1356"},{"key":"2025082800042276000_35.7.49.25","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood.V88.8.2819.bloodjournal8882819","article-title":"Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals","volume":"88","author":"Anderlini","year":"1996","journal-title":"Blood"},{"key":"2025082800042276000_35.7.49.26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00001813-199606000-00003","article-title":"Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia","volume":"7","author":"Avil\u00e9s","year":"1996","journal-title":"Anti-cancer Drugs"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.1997.35749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:04:33Z","timestamp":1756364673000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.1997.35749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1997,7,1]]},"published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1136\/dtb.1997.35749"],"URL":"https:\/\/doi.org\/10.1136\/dtb.1997.35749","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}